Unravelling the role of iron-catalysed ferroptotic cell death in non-alcoholic steatohepatitis
Cédric Peleman(University of Antwerp), Sven Francque(Inova Health System), Astrid Van den Branden, Wilhelmus J. Kwanten(Antwerp University Hospital), Annelies Van Eyck(University of Antwerp), Benedicte Y. De Winter(University of Antwerp), Behrouz Hassannia(Albert Einstein College of Medicine), Joris De Man(University of Antwerp), Ann Driessen(University of Antwerp), Tom Vanden Berghe(University of Antwerp), Christophe Van Steenkiste(University of Antwerp), Luisa Vonghia(Antwerp University Hospital), Lieve Vits(University of Antwerp), Ine Koeken(University of Antwerp), Geraldine Veeckmans(University of Antwerp), Luc Van Nassauw(University of Antwerp), Els Goeman, Emily Van San(University of Antwerp)
Cited by 0
Related Papers
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Hepatology|2023|2.9k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Journal of Hepatology|2023|2.7k
EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
|Journal of Hepatology|2024|1.6k
Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
|Gastroenterology|2016|1k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Annals of Hepatology|2023|789